1. Home
  2. TRTX vs SCTX Comparison

TRTX vs SCTX Comparison

Compare TRTX & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TPG RE Finance Trust Inc.

TRTX

TPG RE Finance Trust Inc.

N/A

Current Price

$7.78

Market Cap

660.2M

Sector

Real Estate

ML Signal

N/A

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

N/A

Current Price

$31.63

Market Cap

536.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRTX
SCTX
Founded
2014
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
660.2M
536.5M
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
TRTX
SCTX
Price
$7.78
$31.63
Analyst Decision
Buy
Analyst Count
4
0
Target Price
$9.83
N/A
AVG Volume (30 Days)
773.7K
215.2K
Earning Date
04-28-2026
N/A
Dividend Yield
11.55%
N/A
EPS Growth
N/A
N/A
EPS
0.19
N/A
Revenue
N/A
N/A
Revenue This Year
$8.78
N/A
Revenue Next Year
$4.14
N/A
P/E Ratio
$41.05
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.57
$17.31
52 Week High
$9.85
$39.60

Technical Indicators

Market Signals
Indicator
TRTX
SCTX
Relative Strength Index (RSI) 45.60 58.65
Support Level $7.57 $27.20
Resistance Level $8.74 $39.60
Average True Range (ATR) 0.12 4.63
MACD 0.02 -0.06
Stochastic Oscillator 51.28 58.48

Price Performance

Historical Comparison
TRTX
SCTX

About TRTX TPG RE Finance Trust Inc.

TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating-rate first mortgage loans that are secured by high-quality commercial real estate properties undergoing some form of transition and value creation.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: